This inventor holds 3 USPTO granted patents. Top assignee: University of Ottawa. Active years: 2012-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2015
Title: Muhammad Asim: Innovator in Estrogenic Compounds
Introduction
Muhammad Asim is a notable inventor based in La Peche, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of estrogenic compounds. With a total of 3 patents to his name, Asim's work is paving the way for advancements in hormone therapies.
Latest Patents
Asim's latest patents focus on the creation of new estrogenic compounds and their pharmaceutical applications. One of his key inventions is titled "Estrogenic compounds, process for their production and pharmaceutical uses thereof." This inventive concept provides new estrogenic compounds of a general formula, which are useful in hormone replacement therapies (HRT/ERT), contraceptives, and estrogenic hormone therapies. Additionally, the patent outlines a process for synthesizing these compounds, showcasing Asim's innovative approach to addressing hormonal health issues.
Career Highlights
Asim is affiliated with the University of Ottawa, where he conducts research and collaborates with fellow scientists. His work has garnered attention for its potential impact on women's health and hormone-related treatments. His dedication to research and innovation has established him as a prominent figure in his field.
Collaborations
Some of Asim's notable coworkers include Tony Durst and Hooman Shadnia. Their collaborative efforts contribute to the advancement of research in estrogenic compounds and their applications in medicine.
Conclusion
Muhammad Asim's contributions to the field of pharmaceutical sciences through his innovative patents on estrogenic compounds highlight his commitment to improving health outcomes. His work continues to inspire advancements in hormone therapies and pharmaceutical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
